Neogen Corporation (NEOG) Stock

Neogen Corporation (NEOG) is a Healthcare stock trading at $9.30 (as of 2026-06-18), with a market capitalization of $1.95B and a trailing P/E of -3.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Neogen Corporation and its subsidiaries develop, manufacture, and market products focused on food and animal safety. It operates in two segments—Food Safety, providing diagnostic tests and related products for detecting substances of concern in food and feed, and Animal Safety, which offers veterinary instruments, pharmaceuticals, vaccines, diagnostics, and related products for animal health.

Valuation — source: SEC EDGAR (first-party)
Price	$9.30
Market Cap	$1.95B
P/E Ratio	-3.2
EV / EBITDA	-5.0
Price / Book	0.93
Price / Sales	2.24
DCF Value (model)	$-7.16
DCF Upside vs Price	-177.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$894.66M
Net Margin	-122.1%
Return on Equity	-29.0%
Debt / Equity	0.39
Current Ratio	3.92
Revenue Growth (YoY)	-4.4%
EPS Growth (YoY)	60.0%
FCF Growth (YoY)	-112.2%

Financial Health — source: SEC EDGAR
Altman Z-Score	0.05 (distress)
Piotroski F-Score	3/9 (weak)

Valuation vs Sector & Industry
Stock P/E	-3.2
Sector P/E (Healthcare)	21.0
Industry P/E (Pharmaceutical Products)	17.3
vs Sector	-115.3%
vs Industry	-118.6%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock, Inc. ($303.05M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Mikhael Nassif
Employees	2,917
Country	US
IPO Date	1989-08-23

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.